Adverse events368

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 368

Type	Event	Organ system	Group	Affected	At risk	Events
other	Dry eye	Eye disorders	Initial Period - Tralokinumab Q2W	3	592	3
other	Dry eye	Eye disorders	Initial Period - Placebo	1	200	1
other	Dry eye	Eye disorders	Maintenance Period - Tralokinumab Q2W	1	91	1
other	Dry eye	Eye disorders	Maintenance Period - Tralokinumab Q4W	0	89	0
other	Dry eye	Eye disorders	Maintenance Period - Placebo	3	46	4
other	Dry eye	Eye disorders	Maintenance Period - Placebo - Tralokinumab Naive	0	31	0
other	Dry eye	Eye disorders	Open-label Period - Tralokinumab Q2W + Optional TCS	5	558	5
other	Dry eye	Eye disorders	Safety Follow-up	1	641	1
other	Conjunctivitis	Infections and infestations	Initial Period - Tralokinumab Q2W	18	592	21
other	Conjunctivitis	Infections and infestations	Initial Period - Placebo	3	200	3
other	Conjunctivitis	Infections and infestations	Maintenance Period - Tralokinumab Q2W	5	91	8
other	Conjunctivitis	Infections and infestations	Maintenance Period - Tralokinumab Q4W	1	89	1
other	Conjunctivitis	Infections and infestations	Maintenance Period - Placebo	2	46	2
other	Conjunctivitis	Infections and infestations	Maintenance Period - Placebo - Tralokinumab Naive	1	31	1
other	Conjunctivitis	Infections and infestations	Open-label Period - Tralokinumab Q2W + Optional TCS	22	558	23
other	Conjunctivitis	Infections and infestations	Safety Follow-up	3	641	3
other	Oral herpes	Infections and infestations	Initial Period - Tralokinumab Q2W	3	592	3
other	Oral herpes	Infections and infestations	Initial Period - Placebo	4	200	4
other	Oral herpes	Infections and infestations	Maintenance Period - Tralokinumab Q2W	1	91	2
other	Oral herpes	Infections and infestations	Maintenance Period - Tralokinumab Q4W	0	89	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03160885/events

API reference For AI assistants

Adverse events368

Sources 3

Read this list from software.